Related Experiment Videos
[Hereditary progressive levodopa sensible: Segawa's syndrome].
J Grippo1, A La Fuente, S M Corral
1División de Neurología, Hospital de Niños R. Gutiérrez, Buenos Aires, Argentina. grippo@fibertel.com.ar
Revista De Neurologia
|July 23, 2002
Summary
This study shows that hereditary progressive childhood dystonia, a genetic disorder, responds well to low-dose Levodopa treatment. Early diagnosis and treatment lead to symptom normalization and long-term recovery in children.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- Hereditary progressive childhood dystonia is a genetic disorder characterized by diurnal symptom fluctuation.
- It is inherited dominantly with variable penetrance and linked to a deficiency in the cyclohydrolase I GTP gene.
Observation:
- Four pediatric patients (ages 7-17) presented with progressive dystonia, ataxia, and gait abnormalities.
- Symptoms exhibited diurnal fluctuations, and standard diagnostic tests were normal.
- Neurological symptoms began between ages 2.5 and 5 years.
Findings:
- Patients responded exceptionally well to low-dose Levodopa (30-60 mg/day).
- All four patients achieved asymptomatic status after 4-8 years of continuous treatment.
- Treatment resulted in neurological normalization without reported side effects.
Implications:
- Early diagnosis of fluctuating childhood dystonia is crucial.
- Low-dose Levodopa is an effective and safe long-term treatment for this condition.
- Genetic testing for cyclohydrolase I GTP deficiency can aid diagnosis.